LOPINAVIR (AN HIV PROTEASE INHIBITOR) IMPAIRS UTERINE REMODELING DURING PREGNANCY
Exposure to protease inhibitor (PI) based combination antiretroviral therapy (cART) during pregnancy; especially Lopinavir (LPV) based cART during periconception, increases the prevalence of preterm delivery and low birth weight. PIs may contribute to these adverse events by lowering progesterone (P4) levels. P4 plays a central role in uterine preparation for pregnancy, and a critical P4-dependent…